11-68312715-A-G

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_002335.4(LRP5):ā€‹c.1A>Gā€‹(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000338 in 888,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā˜…ā˜…).

Frequency

Genomes: not found (cov: 31)
Exomes š‘“: 0.0000034 ( 0 hom. )

Consequence

LRP5
NM_002335.4 start_lost

Scores

3
5
7

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 1.75
Variant links:
Genes affected
LRP5 (HGNC:6697): (LDL receptor related protein 5) This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-68312715-A-G is Pathogenic according to our data. Variant chr11-68312715-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1702012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LRP5NM_002335.4 linkuse as main transcriptc.1A>G p.Met1? start_lost 1/23 ENST00000294304.12 NP_002326.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LRP5ENST00000294304.12 linkuse as main transcriptc.1A>G p.Met1? start_lost 1/231 NM_002335.4 ENSP00000294304 P1
LRP5ENST00000529993.5 linkuse as main transcriptc.1A>G p.Met1? start_lost, NMD_transcript_variant 1/231 ENSP00000436652

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
0.00000338
AC:
3
AN:
888420
Hom.:
0
Cov.:
28
AF XY:
0.00000238
AC XY:
1
AN XY:
420286
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000271
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000251
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Osteogenesis imperfecta Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenOct 01, 2018- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 12, 2024This sequence change affects the initiator methionine of the LRP5 mRNA. The next in-frame methionine is located at codon 165. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with LRP5-related conditions. ClinVar contains an entry for this variant (Variation ID: 1702012). This variant disrupts a region of the LRP5 protein in which other variant(s) (p.Trp79Arg) have been determined to be pathogenic (PMID: 25384351, 28192794). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Uncertain
-0.040
CADD
Benign
20
DANN
Benign
0.76
DEOGEN2
Benign
0.27
T
Eigen
Benign
-0.57
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.034
N
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.99
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Uncertain
-0.15
T
MutationTaster
Benign
1.0
D
PROVEAN
Benign
0.030
N
REVEL
Uncertain
0.38
Sift
Pathogenic
0.0
D
Polyphen
0.0060
B
Vest4
0.48
MutPred
0.89
Loss of catalytic residue at M1 (P = 0.161);
MVP
0.88
ClinPred
0.12
T
GERP RS
0.81
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.80
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-68080183; API